Skip to main content
Premium Trial:

Request an Annual Quote

Invitae Completes $120M Series F Financing

NEW YORK (GenomeWeb) – Invitae said on Monday that it completed a Series F financing round that raised $120 million.

The San Francisco-based genetic diagnostics firm will use the funds to continue building out its infrastructure and expand its global business, it said. New investors included the Broe Group, Decheng Capital, Deerfield Management, OrbiMed, Perceptive Advisors, Rock Springs Capital, and Wellington Management, and others.

Existing investors Casdin Capital, Genesys Capital, Genomic Health, Invitae Founder and CEO Randy Scott, Redmile Group, and Thomas McNerney & Partners also participated in the round.

Invitae was originally formed as a wholly owned subsidiary of Genomic Health in early 2012 and became an independent company later that year, combining with genetics firm Locus Development. It specializes in genetic diagnostics for hereditary disorders and currently offers a test with more than 200 genes for diagnosing genetic disorders associated with cancer, cardiology, neurology, and pediatrics.

Last December, the company raised $40 million in Series E financing. Invitae has raised a total of $207 million since its founding, it said.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.